🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Wonderful meeting with a wide panel of superexperts! Great job by silke gillessen and aurelius omlin in organising APCCC Ente Ospedaliero Cantonale

For Patients With #BladderCancer Undergoing Radical Cystectomy, Robot-Assisted Laparoscopy With ICUD Was Associated With Better Survival And Fewer Serious Complications Compared With Open Surgery, Study Finds. #UroSoMe Source➡️ow.ly/5vpi50IXr3U

Congrats Nicola Fossati for the wonderful wedding! All the best to the both of you. Viva gli sposi!!!

📢Applications for the Certificate of Advanced Studies in #ProstateCancer are still open! APPLY NOW and improve your clinical and scientific capability. 👩‍🔬medical doctors and natural scientists 🗓️Deadline:1 October 2022 🔗bit.ly/3PwyAii usiuniversity #esoncology

ESOncology usiuniversity Proud to be the Executive scientific Director of the Programme together with silke gillessen and Andrea Gallina ! Send us your application! We have created a Programme with a fantastic faculty!!

⏰The deadline to apply for the ESO's CTC Fellowship programme for doctors is the📅19 September 2022. Don't miss the opportunity to increase your knowledge in oncology with high standard clinical practice and scientific tutorship. 👉bit.ly/3QkVJpq #oncoalert #meded

Finally out our correspondence in the Lancet! silke gillessen Thomas Zilli Fabio Turco The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy thelancet.com/journals/lance…

APPLY to the CAS in #ProstateCancer! This part-time Course includes:⠀⠀⠀⠀⠀ - participation to EAU 2023, EMUC 2023 and APCCC 2024 - 6 online modules & 3 in presence seminars. Apply by🗓️30 Oct 2022👉bit.ly/3PwyAii silke gillessen Ursula Vogl Andrea Gallina

🔥 Just published on Eur Urol Focus: Impact of Early DVC Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial ➡️ Have a look at it here (50-days free access): authors.elsevier.com/a/1foRZ8Yy0LMy…

Premio Roth 22 all'immenso Prof. Rigatti. #SIU22

What an outstanding panel today at the AUA/EAU corner at #SIU22. Thanks for joining to Arnulf Stenzl Firas Abdollah Alice Yu Alex Mottrie European Association of Urology (EAU) Amer. Urol. Assn. Società Italiana di Urologia

Ti interessi di prevenzione e di accertamenti diagnostici precoci? il FORUM PROSTATA è il luogo ideale in cui porre domande ai nostri esperti e informarti sul tema. L'evento è domani, gio 24 nov al Palacinema di Locarno. È ancora possibile iscriversi! QUI: eventi.eoc.ch/cpsi/

Le domande essenziali: Come possiamo rafforzare la collaborazione con i medici di famiglia e il coinvolgimento dei pazienti Andrea Gallina Thomas Zilli Ursula Vogl

Il mese dedicato alla prevenzione del tumore alla prostata si è concluso, ma la prevenzione non deve fermarsi. #EOC Vi proponiamo questo interessante servizio del Quotidiano - RSI. rsi.ch/play/tv/redire… via RSI

Collaboratori e pazienti del Civico e del Cardiocentro sono stati allietati oggi dalla visita dell'On. De Rosa che ringraziamo enormemente per il tempo dedicato. Nelle foto: i Dir. Martinetti e Dati, il Pres. Cda EOC Sanvido, Primari e Viceprimari e collaboratori di vari reparti

In seguito alla Conferenza APCCC Lugano 2022 - organizzata da Gillessen e Omlin - la prestigiosa rivista European Urology ha recentemente pubblicato un articolo sulle criticità e controversie della gestione clinica dei tumori alla prostata. sciencedirect.com/science/articl… #APCCC2022

Updated treatment recommendations for prostate cancer (ESMO) 💥Updated guideline with current results of treatment options such as triple combinations, PARP inhibitors, Lu-177👇 ESMO - Eur. Oncology Annals of Oncology OncoAlert annalsofoncology.org/article/S0923-…

EOC and IOSI playing a lead role at the most important Annual Urologic Meeting. At EAU Paris 2024, Ticino rulez!!!!

"Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives" Just out on Clinical Genitourinary Cancer Prostate Cancer is typically hormone-dependent, with ADT (standard treatment for metastatic disease for over 80 years). Over time, ADT💊